HighCape Capital, L.P. - Jun 7, 2021 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
Director, 10%+ Owner
Signature
/s/ Kevin L. Rakin
Stock symbol
ELUT
Transactions as of
Jun 7, 2021
Transactions value $
$0
Form type
4
Date filed
6/9/2021, 05:44 PM
Next filing
Dec 10, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELUT Stock Option (Right to Buy) Award $0 +14.1K $0.00 14.1K Jun 7, 2021 Class A Common Stock 14.1K $10.41 See footnote F1, F2
transaction ELUT Stock Option (Right to Buy) Award $0 +14.1K $0.00 14.1K Jun 7, 2021 Class A Common Stock 14.1K $10.41 See footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date.
F2 Held by Kevin L. Rakin as non-employee member of the Issuer's board of directors
F3 Held by W. Matthew Zuga as non-employee member of the Issuer's board of directors